Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Commonalities"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
product_txtF_mv:"National Center for Biotechnology Information"
Showing
141
-
160
of
790
Search:
'"Commonalities"'
,
query time: 0.01s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
141
CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Lamivudine (Dovato -- ViiV healthcare ULC) : indication: as a complete regimen for the treatment of human immunode...
Published 2019
CADTH
“
...CADTH
common
drug review...
”
Read Now
142
Clinical review report: Dupilumab (Dupixent) (Sanofi genzyme, a division of Sanofi-Aventis Canada Inc.) : indication : indicated for the treatment of patients aged 12 years and old...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
143
Clinical review report: Tiotropium bromide monohydrate and olodaterol hydrochloride (Inspiolto respimat) for oral inhalation
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
144
CADTH Canadian Drug Expert Committee recommendation: Baricitinib (Olumiant -- Eli Lilly Canada Inc.) : indication : for use in combination with methotrexate (MTX) for the treatment...
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
145
CADTH Canadian Drug Expert Committee recommendation: Apomorphine hydrochloride (Movapo -- Paladin Labs Inc.) : indication : Parkinson's disease
Published 2018
CADTH
“
...CADTH
common
drug review...
”
Read Now
146
CADTH Canadian Drug Expert Committee final recommendation: Omalizumab -- resubmission (Xolair -- Novartis Pharmaceuticals Canada Inc.) : indication: asthma
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
147
CADTH Canadian drug expert committee recommendation: Latanoprost (Monoprost -- Laboratoires Thea) : indication : glaucoma and ocular hypertension
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
148
CADTH Canadian Drug Expert Committee recommendation: Migalastat (Galafold -- Amicus therapeutics) : indication : Fabry disease
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
149
Patient group input submissions: Sapropterin dihydrochloride (Kuvan) for phenylketonuria (PKU)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
150
Pharmacoeconomic review report: Cysteamine delayed-release capsules (Procysbi), Horizon Pharma Ireland Ltd
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
151
Patient group input submissions: Obeticholic acid (Ocaliva) : (Intercept Pharma Canada, Inc.)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
152
Patient group input submissions: Ixekizumab (Taltz) for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or photothe...
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
153
CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Rilpivirine (Juluca -- ViiV healthcare) : indication : the treatment of human immunodeficiency virus (HIV-1) infec...
Published 2018
CADTH
“
...CADTH
common
drug review...
”
Read Now
154
Pharmacoeconomic review report: Benralizumab (Fasenra) (AstraZeneca Canada Inc.) : indication : an add-on maintenance treatment of adult patients with severe eosinophilic asthma
Published 2018
CADTH
“
...CADTH
common
drug review...
”
Read Now
155
Clinical review report: Dolutegravir/Lamivudine (Dovato) : (ViiV Healthcare ULC)
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
156
CADTH Canadian drug expert committee recommendation: Siponimod (Mayzent -- Novartis Pharmaceuticals Canada Inc.) : indication : secondary progressive multiple sclerosis
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
157
CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin (Steglatro -- Merck Canada Inc.) : indication : diabetes mellitus, type 2
Published 2019
CADTH
“
...CADTH
common
drug review...
”
Read Now
158
Pharmacoeconomic review report: Cyclosporine (Verkazia) (Santen Canada inc.) : indication: treatment of severe vernal keratoconjunctivitis in children from four years of age throug...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
159
Clinical review report: Fluticasone Propionate (Aermony Respiclick) (Teva Canada Innovation) : indication : for the maintenance treatment of steroid-responsive bronchial asthma as...
Published 2019
CADTH
“
...CADTH
common
drug review...
”
Read Now
160
Pharmacoeconomic review report: Vortioxetine hydrobromide (Trintellix) (Lundbeck Canada Inc.) : indication : the treatment of major depressive disorder in adults
Published 2020
CADTH
“
...CADTH
common
drug review...
”
3
4
5
6
7
8
9
10
11
12
13
Back
Narrow Search
Remove Filters
Clear Filter
Collection: National Center for Biotechnology Information
Year of Publication
From:
To:
Classification
610 - Medicine & health
581
330 - Economics
256
140 - Specific philosophical schools
83
700 - The arts; fine & decorative arts
76
580 - Plants (Botany)
11
380 - Commerce, communications & transportation
7
more ...
615 - Pharmacology & therapeutics
4
see all ...
less ...
Language
English
790
Collection
National Center for Biotechnology Information
Author
Canadian Agency for Drugs and Technologies in Health
729
CADTH Canadian Drug Expert Committee
210
Canadian Diabetes Association
4
Kidney Foundation of Canada
2
Multiple Sclerosis Society of Canada
2
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?page=8&filter%5B%5D=product_txtF_mv%3A%22National+Center+for+Biotechnology+Information%22&lookfor=%22Commonalities%22&type=Series
Send by Email
×
Loading...